Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines

We emphasize that TMX is an inhibitor of the p-PKC-pan and that these combination is more effective in the reduction of proliferation and in the increase of apoptosis than each drug alone, which presents a new therapeutic strategy in GBM treatment.